路透7月7日 - 美国食品药品监督管理局周二表示,已批准Vera Therapeutics公司的一款 VERA.O 药物,用于治疗患有潜在致命性肾脏疾病的患者。
路透7月7日 - 美国食品药品监督管理局周二表示,已批准Vera Therapeutics公司的一款 VERA.O 药物,用于治疗患有潜在致命性肾脏疾病的患者。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.